Tirzepatide – 30mg

4.9 (128 Reviews)

In Stock

SKU: PEP-TIRZ-30

$170.00 $280.00

Tirzepatide is a synthetic research peptide functioning as a dual agonist of the GIP and GLP-1 receptors. High affinity binding profile designed for metabolic pathway investigation. Provided as a lyophilized powder.

Strictly for Laboratory Research Use Only.
Not for human or animal consumption. Not for diagnostic or therapeutic use.

≥99% Purity

3rd Party Tested

Same Day Ship

Secure Payment

Two Receptors, One Molecule: The Science of Dual Activation

Tirzepatide represents a novel approach in incretin-based peptide research. Unlike single-target compounds like Semaglutide, it activates two key receptors simultaneously: GLP-1 (Glucagon-like peptide-1) and GIP (Glucose-dependent insulinotropic polypeptide).

This dual-agonist mechanism has been extensively documented in peer-reviewed literature for its interaction with metabolic pathways including glucose homeostasis and incretin signaling mechanisms. Published research indicates this combination creates a synergistic effect, where the combined receptor activation produces distinct outcomes compared to single-receptor agonism.

Research Highlights

Activates both GLP-1 and GIP receptors simultaneously.
First compound designed with this specific dual-agonist mechanism.
Exhibits high binding affinity to GIP receptors (comparable to endogenous GIP).
Demonstrates extended half-life suitable for weekly research protocols.

Key Specifications

Format	Lyophilized Powder
Quantity	30mg
Purity	≥99% (HPLC)
Sequence	Synthetic Analog
Storage	-20°C (Freezer)

Scientific Literature & Applications

Tirzepatide is a valuable tool for researchers exploring dual-receptor agonism and incretin pathway interactions. Because it affects two signaling pathways simultaneously, it enables investigation of receptor cross-talk and synergistic mechanisms that were difficult to study with single-target compounds.

References

Jastreboff AM, et al.
"Tirzepatide once weekly for the treatment of obesity." N Engl J Med. 2022.
Frias JP, et al.
"Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist." Lancet. 2018.

Quality Assurance & Testing

At Prime Lab Peptides, quality is not a variable—it's a constant. Every batch of Tirzepatide is subjected to rigorous analytical testing to ensure identity and purity.

Our standard is ≥99% purity as determined by High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). This ensures that your research is not compromised by impurities or degradation products.

Certificate of Analysis (COA) available upon request for verified researchers.

Shipping & Handling

We understand that time and stability are critical for research materials.

Same-Day Shipping: Orders placed before 2 PM EST (Mon-Fri) are processed and shipped the same day.
Secure Packaging: Products are shipped in durable, temperature-stable packaging to ensure integrity upon arrival.
Free Shipping: Available on orders over $200 (domestic).

Note: Lyophilized peptides are stable at room temperature for short periods during transit, but should be stored at -20°C upon receipt.